Clinical trial
Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With…
NCT00287378 · University of North Carolina, Chapel Hill, Other · Terminated
Key facts
| NCT number | NCT00287378 |
|---|---|
| Title | Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab |
| Official title | Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Institutes of Health (NIH) NIH Genentech, Inc. Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Asthma, Allergy |
| Intervention type | Drug |
| Interventions | omalizumab |
| Enrollment | 1 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 6, 2006 |
| Last update posted | Jun 30, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: